RCEL · AVITA Medical, Inc. · Investor Relations
$15.65
-1.06 (-6.34%)
At close · Oct 30
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's liquidity position and the Company's current forecast of operating results and cash flows, management determined there is substantial doubt about the Company's ability to continue as a going concern over the next twelve months following the date of issuance of these Consolidated Financial Statements due to the Company's debt repayment obligations, recurring losses, and historical negative cash flows.”View the 10-Q filed Aug 6, 2026
Market Cap
$484.01M
Shares
30.93M
Volume · Oct 30
597.05K
Avg daily vol (3M)
484.46K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-13 | 2026 ASX Limited full year results | Results publication |
| 2026-08-06 | Q2 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-05-14 | Q1 FY2026 Earnings conference call (announced in 8-K) | Earnings call |
| 2026-02-12 | Q4 FY2025 Earnings conference call (announced in 8-K) | Earnings call |